Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RWJ-51084 is an experimental small molecule compound belonging to the class of benzothiazoles. Its chemical formula is C19H25N5O2S and it has a molecular weight of approximately 387.5 g/mol[1][2][3]. The drug has not been approved for any indication and there are no known clinical trials or approved uses in any jurisdiction[3]. Detailed information about its mechanism of action or therapeutic target is not available in public databases as of June 2025.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on RWJ-51084.